Tekla Life Sciences Investors Stock Forecast
Tekla Life Sciences Investors stock price ended at $14.29 on Tuesday, after gaining 0.210%.
(Updated on Jul 02, 2024)
The Tekla Life Sciences Investors stock price gained 0.210% on the last trading day (Tuesday, 2nd Jul 2024), rising from $14.26 to $14.29. During the last trading day the stock fluctuated 0.98% from a day low at $14.24 to a day high of $14.38. The price has risen in 7 of the last 10 days and is up by 3.55% over the past 2 weeks. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 6 thousand more shares were traded than the day before. In total, 89 thousand shares were bought and sold for approximately $1.27 million.
The stock lies in the middle of a wide and weak rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the stock is expected to rise 7.87% during the next 3 months and, with a 90% probability hold a price between $14.51 and $15.98 at the end of this 3-month period.
Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.
HQL Signals & Forecast
Mostly positive signals in the chart today. The Tekla Life Sciences Investors stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock. Also, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down, there will be some support from the lines at $14.19 and $13.82. A breakdown below any of these levels will issue sell signals. A buy signal was issued from a pivot bottom point on Wednesday, May 29, 2024, and so far it has risen 9.50%. Further rise is indicated until a new top pivot has been found. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Tekla Life Sciences Investors has increased volume and follows the last lift in the price. This is considered to be a technical positive sign as volume should follow the price-formation. Higher liquidity also reduces the general risk.
Support, Risk & Stop-loss for Tekla Life Sciences Investors stock
Tekla Life Sciences Investors finds support from accumulated volume at $14.26 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.
In general the stock tends to have very controlled movements and with good liquidity the risk is considered very low in this stock. During the last day, the stock moved $0.140 between high and low, or 0.98%. For the last week the stock has had daily average volatility of 0.786%.
Our recommended stop-loss: $13.78 (-3.56%) (This stock has low daily movements and this gives low risk. There is a buy signal from a pivot bottom found 31 days ago.)
Trading Expectations (HQL) For The Upcoming Trading Day Of Wednesday 3rd
For the upcoming trading day on Wednesday, 3rd we expect Tekla Life Sciences Investors to open at $14.30, and during the day (based on 14 day Average True Range), to move between $14.13 and $14.45, which gives a possible trading interval of +/-$0.161 (+/-1.13%) up or down from last closing price. If Tekla Life Sciences Investors takes out the full calculated possible swing range there will be an estimated 2.26% move between the lowest and the highest trading price during the day.
With no resistance above and support from accumulated volume @ $14.26, some $0.0300 (0.21%) from the current price of $14.29, our system finds the risk reward attractive.
Is Tekla Life Sciences Investors stock A Buy?
Tekla Life Sciences Investors holds several positive signals and is within a weak rising trend. As the old saying says, "Let the trend be your friend.'". We therefore consider it to be a good choice at these current levels and we are expecting further gains during the next 3 months.
Current score: 7.146 Strong Buy Candidate Unchanged
Predicted Opening Price for Tekla Life Sciences Investors of Wednesday, July 3, 2024
Fair opening price July 3, 2024 | Current price |
---|---|
$14.30 ( 0.0933%) | $14.29 |
The predicted opening price is based on yesterday's movements between high, low, and closing price.
Trading levels for HQL
Fibonacci Support & Resistance Levels
Level | Price | |
---|---|---|
R3 | 14.44 | 1.07% |
R2 | 14.39 | 0.699% |
R1 | 14.36 | 0.468% |
Price | 14.29 | |
S1 | 14.25 | -0.281% |
S2 | 14.22 | -0.512% |
S3 | 14.16 | -0.89% |
Accumulated Volume Support & Resistance Levels
Level | Price | |
---|---|---|
R3 | 0 | - |
R2 | 0 | - |
R1 | 0 | - |
Price | 14.29 | |
S1 | 14.26 | -0.210% |
S2 | 14.17 | -0.84% |
S3 | 12.79 | -10.50% |
HQL Dividend Payout History
# | Ex-Date | Pay Date | Amount | Yield | |
---|---|---|---|---|---|
1 | May 09, 2024 | May 22, 2024 | Jun 28, 2024 | $0.480 | 3.39% |
2 | Feb 21, 2024 | Feb 21, 2024 | Mar 28, 2024 | $0.390 | 2.86% |
3 | Nov 09, 2023 | Nov 21, 2023 | Jan 10, 2024 | $0.300 | 2.09% |
4 | Aug 15, 2023 | Aug 24, 2023 | Sep 29, 2023 | $0.320 | 2.57% |
5 | May 15, 2023 | May 24, 2023 | Jun 30, 2023 | $0.320 | 2.36% |
FAQ
Click here for our free guide on how to buy Tekla Life Sciences Investors Stock.